Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial F₁F₀ ATP synthase is a multi-subunit enzyme complex essential for the energy metabolism of mycobacteria, including Mycobacterium tuberculosis [1, 4]. It functions as the primary catalyst for adenosine triphosphate (ATP) synthesis via oxidative phosphorylation, utilizing the proton motive force generated by the electron transport chain [2, 5]. The enzyme consists of a membrane-embedded F₀ sector involved in proton translocation and a cytoplasmic F₁ sector where ATP is synthesized from ADP and inorganic phosphate [5, 12]. This target is particularly vital because mycobacteria rely on it for survival during both active growth and latent phases of infection [4, 12]. The clinical significance of this target was established with the approval of bedaquiline, a diarylquinoline that selectively binds to the c-ring of the mycobacterial F₀ sector [6, 9]. This interaction inhibits the rotation of the enzyme, leading to a rapid depletion of ATP and subsequent bacterial death [9, 13]. While bedaquiline is a cornerstone in treating multidrug-resistant tuberculosis, its use is associated with safety concerns such as QTc prolongation and potential hepatotoxicity [1, 11]. Research continues into next-generation inhibitors like TBAJ-876, which aim to provide improved safety profiles and broader efficacy against non-tuberculous mycobacteria [2, 6].
Inhibition of the c-ring rotation within the F0 sector, which halts the catalytic activity of the F1 sector and depletes cellular ATP levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial F₁F₀ ATP synthase (ATP synthase).